{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:52:39Z","timestamp":1770461559004,"version":"3.49.0"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019054","name":"Changsha Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Retinopathy of prematurity (ROP) is the main risk factor for vision-threatening disease in premature infants with low birth weight. An accumulating number of independent studies have focused on ROP pathogenesis and have demonstrated that laser photocoagulation therapy and\/or anti-VEGF treatment are effective. However, early diagnosis of ROP is still critical. At present, the main method of ROP screening is based on binocular indirect ophthalmoscopy. However, the judgment of whether ROP occurs and whether treatment is necessary depends largely on ophthalmologists with a great deal of experience. Therefore, it is essential to develop a simple, accurate and effective diagnostic method. This review describes recent findings on novel biomarkers for the prediction, diagnosis and prognosis of ROP patients. The novel biomarkers were separated into the following categories: metabolites, cytokines and growth factors, non-coding RNAs, iconography, gut microbiota, oxidative stress biomarkers, and others. Biomarkers with high sensitivity and specificity are urgently needed for the clinical applications of ROP. In addition, using non-invasive or minimally invasive methods to obtain samples is also important. Our review provides an overview of potential biomarkers of ROP.<\/jats:p>","DOI":"10.3389\/fmed.2022.840030","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:51:11Z","timestamp":1643809871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Novel Potential Biomarkers for Retinopathy of Prematurity"],"prefix":"10.3389","volume":"9","author":[{"given":"Wei","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zicong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yedi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","article-title":"Epidemiology of blindness in children","volume":"102","author":"Solebo","year":"2017","journal-title":"Arch Dis Child."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.ophtha.2019.11.026","article-title":"Retinopathy of prematurity incidence in children","volume":"127","author":"Good","year":"2020","journal-title":"Ophthalmology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01679-8.","article-title":"Evolving outcomes of surgery for retinal detachment in retinopathy of prematurity: the need for a national service in the United Kingdom: an audit of surgery for acute tractional retinal detachment complicating ROP in the UK","author":"Patel","year":"2021","journal-title":"Eye."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1167\/iovs.18-24776","article-title":"The association between retinopathy of prematurity and ocular growth","volume":"60","author":"Kardaras","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.ophtha.2020.01.034","article-title":"Incidence and early course of retinopathy of prematurity","volume":"127","author":"Palmer","year":"2020","journal-title":"Ophthalmology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41433-019-0620-y","article-title":"ROP in Asia","volume":"34","author":"Adams","year":"2020","journal-title":"Eye."},{"key":"B12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1051\/medsci\/2020163","volume":"36","author":"Daruich","year":"2020","journal-title":"Med Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s10792-020-01543-w","article-title":"Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP study (ITCROPS) database report number 9","volume":"40","author":"Laveti","year":"2020","journal-title":"Int Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of prematurity treatment: Asian perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaapos.2005.11.019","article-title":"RetCam imaging for retinopathy of prematurity screening","volume":"10","author":"Wu","year":"2006","journal-title":"J AAPOS."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/IAE.0000000000001719","article-title":"The cutting edge of retinopathy of prematurity care: expanding the boundaries of diagnosis and treatment","volume":"37","author":"Yonekawa","year":"2017","journal-title":"Retina."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.9.2.5","article-title":"Artificial intelligence in retinopathy of prematurity diagnosis","volume":"9","author":"Scruggs","year":"2020","journal-title":"Transl Vis Sci Technol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00417-019-04470-4","article-title":"Smartphone-based fundus photography for screening of plus-disease retinopathy of prematurity","volume":"257","author":"Patel","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.semperi.2019.05.006","article-title":"Retinopathy of prematurity prevention, screening and treatment programmes: progress in India","volume":"43","author":"Chawla","year":"2019","journal-title":"Semin Perinatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/ceo.13160","article-title":"Retinopathy of prematurity: the high cost of screening regional and remote infants","volume":"46","author":"Yu","year":"2018","journal-title":"Clin Exp Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.semperi.2019.05.010","article-title":"The role of retinal photography and telemedicine in ROP screening","volume":"43","author":"Quinn","year":"2019","journal-title":"Semin Perinatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5144\/0256-4947.2020.87","article-title":"Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia","volume":"40","author":"Mgharbil","year":"2020","journal-title":"Ann Saudi Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","article-title":"Epilepsy biomarkers - toward etiology and pathology specificity","volume":"123","author":"Pitk\u00e4nen","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1158\/0008-5472.CAN-18-0887","article-title":"Tumor-educated platelets as a noninvasive biomarker source for cancer detection and progression monitoring","volume":"78","author":"Best","year":"2018","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"102064","DOI":"10.1016\/j.ctrv.2020.102064","article-title":"Biomarkers for HER2-positive metastatic breast cancer: beyond hormone receptors","volume":"88","author":"Dieci","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/annonc\/mdz141","article-title":"EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer","volume":"30","author":"Hastings","year":"2019","journal-title":"Ann Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/metabo10090374","article-title":"Metabolomic profiling in neuromyelitis optica spectrum disorder biomarker discovery","volume":"10","author":"Thoman","year":"2020","journal-title":"Metabolites"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1167\/iovs.18-24106","article-title":"Prediction of individual disease conversion in early amd using artificial intelligence","volume":"59","author":"Schmidt-Erfurth","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamaophthalmol.2020.1376","article-title":"Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography","volume":"138","author":"Waldstein","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.4103\/ijo.IJO_893_18","article-title":"Choroidal biomarkers","volume":"66","author":"Pichi","year":"2018","journal-title":"Indian J Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/bjophthalmol-2014-305186","article-title":"Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy","volume":"98","author":"Ritter","year":"2014","journal-title":"Br J Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/life11111119","article-title":"Metabolism in retinopathy of prematurity","volume":"11","author":"Tomita","year":"2021","journal-title":"Life."},{"key":"B36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.61.2.12","article-title":"targeted blood metabolomic study on retinopathy of prematurity","volume":"61","author":"Yang","year":"2020","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.exer.2020.108198","article-title":"Plasma metabolites in treatment-requiring retinopathy of prematurity: potential biomarkers identified by metabolomics","volume":"199","author":"Zhou","year":"2020","journal-title":"Exp Eye Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.7150\/ijms.63603","article-title":"Plasma levels of amino acids and derivatives in retinopathy of prematurity","volume":"18","author":"Zhou","year":"2021","journal-title":"Int J Med Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fphar.2020.00873","article-title":"Exploration of oxygen-induced retinopathy model to discover new therapeutic drug targets in retinopathies","volume":"11","author":"V\u00e4h\u00e4tupa","year":"2020","journal-title":"Front Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"107855","DOI":"10.1016\/j.exer.2019.107855","article-title":"Metabolomic changes of blood plasma associated with two phases of rat OIR","volume":"190","author":"Lu","year":"2020","journal-title":"Exp Eye Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"158939","DOI":"10.1016\/j.bbalip.2021.158939","article-title":"Sphingolipidomics of serum in extremely preterm infants: association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity","volume":"1866","author":"Nilsson","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaophthalmol.2017.6658","article-title":"Association of retinopathy of prematurity with low levels of arachidonic acid: a secondary analysis of a randomized clinical trial","volume":"136","author":"L\u00f6fqvist","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1167\/iovs.19-27258","article-title":"Immune and inflammatory proteins in cord blood as predictive biomarkers of retinopathy of prematurity in preterm infants","volume":"60","author":"Park","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1167\/iovs.61.5.42","article-title":"Inflammatory and angiogenic mediators in amniotic fluid are associated with the development of retinopathy of prematurity in preterm infants","volume":"61","author":"Woo","year":"2020","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/apm.12223","article-title":"Serum concentrations of cytokines in infants with retinopathy of prematurity","volume":"122","author":"Yu","year":"2014","journal-title":"Apmis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1167\/iovs.17-21931","article-title":"Systemic inflammation-associated proteins and retinopathy of prematurity in infants born before the 28th week of gestation","volume":"58","author":"Holm","year":"2017","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1203\/PDR.0b013e3181d01a36","article-title":"Perinatal systemic inflammatory response syndrome and retinopathy of prematurity","volume":"67","author":"Sood","year":"2010","journal-title":"Pediatr Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1055\/s-0037-1601486","article-title":"The alteration and significance of erythropoietin serum levels in preterm infants with retinopathy of prematurity","volume":"34","author":"Yang","year":"2017","journal-title":"Am J Perinatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fimmu.2017.01868","article-title":"Abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity","volume":"8","author":"Rathi","year":"2017","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1386207322666190325120244","article-title":"Can IL-33 and endocan be new markers for retinopathy of prematurity?","volume":"22","author":"Cakir","year":"2019","journal-title":"Comb Chem High Throughput Screen."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00417-018-4034-5","article-title":"Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab","volume":"256","author":"Lyu","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000317779","article-title":"Proliferative retinopathy is associated with impaired increase in BDNF and RANTES expression levels after preterm birth","volume":"98","author":"Hellgren","year":"2010","journal-title":"Neonatology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ghir.2017.11.006","article-title":"Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity","volume":"39","author":"Hellgren","year":"2018","journal-title":"Growth Horm IGF Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/IAE.0000000000001247","article-title":"Postnatal serum insulin-like growth factor I and retinopathy of. prematurity","volume":"37","author":"Jensen","year":"2017","journal-title":"Retina."},{"key":"B57","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1651-2227.2009.01677.x","article-title":"Serum levels of IGF1 are a useful predictor of retinopathy of prematurity","volume":"99","author":"P\u00e9rez-Mu\u00f1uzuri","year":"2010","journal-title":"Acta Paediatr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3928\/01913913-20110531-01","article-title":"IGF-I and visfatin levels in retinopathy of prematurity","volume":"49","author":"Cekmez","year":"2012","journal-title":"J Pediatr Ophthalmol Strabismus."},{"key":"B61","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3928\/23258160-20131105-05","article-title":"Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity","volume":"44","author":"Yenice","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.3.2","article-title":"Tear fluid angiogenic factors: potential noninvasive biomarkers for retinopathy of prematurity screening in preterm infants","volume":"62","author":"Vinekar","year":"2021","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1167\/iovs.13-11837","article-title":"The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study","volume":"54","author":"Woo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaapos.2015.04.008","article-title":"Serum neutrophil-to-lymphocyte ratio in retinopathy of prematurity","volume":"19","author":"Kurtul","year":"2015","journal-title":"J AAPOS."},{"key":"B66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","article-title":"Non-coding RNAs regulate alternative splicing in cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J Exp Clin Cancer Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"B69","doi-asserted-by":"publisher","first-page":"194417","DOI":"10.1016\/j.bbagrm.2019.194417","article-title":"Non-coding RNA regulatory networks","volume":"1863","author":"Panni","year":"2020","journal-title":"Biochim Biophys Acta Gene Regul Mech."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/ijms21114020","article-title":"Non-coding RNA: role in gestational diabetes pathophysiology and complications","volume":"21","author":"Filardi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat Biotechnol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature."},{"key":"B73","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer."},{"key":"B74","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7150\/ijms.28047","article-title":"Circular RNA: a novel biomarker and therapeutic target for human cancers","volume":"16","author":"Lei","year":"2019","journal-title":"Int J Med Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fcell.2020.00850","article-title":"CircRNA is a rising star in researches of ocular diseases","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.7150\/thno.19353","article-title":"Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction","volume":"7","author":"Liu","year":"2017","journal-title":"Theranostics."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bby054","article-title":"Trends in the development of miRNA bioinformatics tools","volume":"20","author":"Chen","year":"2019","journal-title":"Brief Bioinform."},{"key":"B78","first-page":"791","article-title":"Effects of microRNA-29a on retinopathy of prematurity by targeting AGT in a mouse model","volume":"9","author":"Chen","year":"2017","journal-title":"Am J Transl Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"174035","DOI":"10.1016\/j.ejphar.2021.174035","article-title":"MicroRNA-126 inhibits pathological retinal neovascularization via suppressing vascular endothelial growth factor expression in a rat model of retinopathy of prematurity","volume":"900","author":"Fan","year":"2021","journal-title":"Eur J Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/eye.2017.193","article-title":"Evaluation of the plasma microRNA levels in stage 3 premature retinopathy with plus disease: preliminary study","volume":"32","author":"Metin","year":"2018","journal-title":"Eye."},{"key":"B81","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms16010840","article-title":"Identification of retinopathy of prematurity related miRNAs in hyperoxia-induced neonatal rats by deep sequencing","volume":"16","author":"Zhao","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.7150\/ijms.35149","article-title":"Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice","volume":"16","author":"Cao","year":"2019","journal-title":"Int J Med Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.7150\/ijms.46209","article-title":"Small RNA sequencing reveals transfer RNA-derived small RNA expression profiles in retinal neovascularization","volume":"17","author":"Peng","year":"2020","journal-title":"Int J Med Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/jcm9092711","article-title":"Oxidative stress markers and the retinopathy of prematurity","volume":"9","author":"Graziosi","year":"2020","journal-title":"J Clin Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2741\/4382","article-title":"Retinopathy of prematurity: an oxidative stress neonatal disease","volume":"21","author":"Stone","year":"2016","journal-title":"Front Biosci."},{"key":"B86","first-page":"413","volume":"108","author":"Ozieb\u0142o-Kupczyk","year":"2006","journal-title":"Klin Oczna."},{"key":"B87","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.lfs.2004.01.025","article-title":"Oxidative stress in neonates: evaluation using specific biomarkers","volume":"75","author":"Tsukahara","year":"2004","journal-title":"Life Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/112067210901900112","article-title":"Oxidative DNA damage in retinopathy of prematurity","volume":"19","author":"Ates","year":"2009","journal-title":"Eur J Ophthalmol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00431-020-03896-x","article-title":"Fetal oxidative stress, micronutrient deficiency and risk of retinopathy of prematurity: a nested case-control study","volume":"180","author":"Agrawal","year":"2021","journal-title":"Eur J Pediatr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"458","DOI":"10.20471\/acc.2018.57.03.08","article-title":"Pro-oxidants and antioxidants in retinopathy of prematurity","volume":"57","author":"Banjac","year":"2018","journal-title":"Acta Clin Croat."},{"key":"B91","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41433-021-01465-6","article-title":"Evaluation of pro-oxidant antioxidant balance in retinopathy of prematurity","volume":"36","author":"Boskabadi","year":"2021","journal-title":"Eye."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1167\/iovs.18-26426","article-title":"Implicating dysbiosis of the gut fungal microbiome in uveitis, an inflammatory disease of the eye","volume":"60","author":"Jayasudha","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fimmu.2019.00232","article-title":"Microbiome and autoimmune uveitis","volume":"10","author":"Horai","year":"2019","journal-title":"Front Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"E4472","DOI":"10.1073\/pnas.1702302114","article-title":"Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration","volume":"114","author":"Rowan","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B95","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/19490976.2018.1435247","article-title":"Gut microbiota modify risk for dietary glycemia-induced age-related macular degeneration","volume":"9","author":"Rowan","year":"2018","journal-title":"Gut Microbes."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/nu10111677","article-title":"The role of diet, micronutrients and the gut microbiota in age-related macular degeneration: new perspectives from the gut?retina axis","volume":"10","author":"Rinninella","year":"2018","journal-title":"Nutrients"},{"key":"B97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.13331","article-title":"Influence of maternal microbiota during pregnancy on infant immunity","volume":"198","author":"Nyangahu","year":"2019","journal-title":"Clin Exp Immunol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01888-7.","article-title":"The bacterial gut microbiome of probiotic-treated very-preterm infants: changes from admission to discharge","author":"Westaway","year":"2021","journal-title":"Pediatr Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3892\/etm.2020.9424","article-title":"Retinopathy of prematurity and neonatal gut microbiome: an interview with professor dimitra skondra, associate professor of ophthalmology and vitreoretinal surgeon at the university of chicago (USA)","volume":"20","author":"Mammas","year":"2020","journal-title":"Exp Ther Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaapos.2020.03.010","article-title":"The early gut microbiome could protect against severe retinopathy of prematurity","volume":"24","author":"Skondra","year":"2020","journal-title":"J aapos."},{"key":"B101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14324","article-title":"Choroidal structural changes in preterm children with and without retinopathy of prematurity","author":"Lavric","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41598-020-79535-0","article-title":"Severe retinopathy of prematurity is associated with early post-natal low platelet count","volume":"11","author":"Parrozzani","year":"2021","journal-title":"Sci Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.pedneo.2017.11.001","article-title":"Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants","volume":"59","author":"Korkmaz","year":"2018","journal-title":"Pediatr Neonatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/eye.2017.76","article-title":"Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study","volume":"31","author":"Stutchfield","year":"2017","journal-title":"Eye."},{"key":"B106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4274\/tjo.galenos.2019.45313","article-title":"Can complete blood count parameters predict retinopathy of prematurity?","volume":"50","author":"Aky\u00fcz \u00dcnsal","year":"2020","journal-title":"Turk J Ophthalmol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ophtha.2015.05.036","article-title":"Frizzled-4 variations associated with retinopathy and intrauterine growth retardation: a potential marker for prematurity and retinopathy","volume":"122","author":"Dailey","year":"2015","journal-title":"Ophthalmology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/1354750X.2020.1783573","article-title":"Feasibility of neonatal haemoglobin A1C as a biomarker for retinopathy of prematurity","volume":"25","author":"Movsas","year":"2020","journal-title":"Biomarkers."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1167\/iovs.09-4723","article-title":"Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity","volume":"51","author":"Pieh","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS."},{"key":"B111","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0378-3782(14)50009-6","article-title":"Use of erythropoietin is associated with threshold retinopathy of prematurity (ROP) in preterm ELBW neonates: a retrospective, cohort study from two large tertiary NICUs in Italy","volume":"90","author":"Manzoni","year":"2014","journal-title":"Early Hum Dev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"605918","DOI":"10.3389\/fnmol.2020.605918","article-title":"The serine protease HTRA-1 is a biomarker for ROP and mediates retinal neovascularization","volume":"13","author":"Owen","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/14767058.2016.1205019","article-title":"Serum lactate levels and perfusion index: are these prognostic factors on mortality and morbidity in very low-birth weight infants?","volume":"30","author":"Tuten","year":"2017","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41390-019-0580-8","article-title":"The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity","volume":"87","author":"Movsas","year":"2020","journal-title":"Pediatr Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1542\/peds.2011-0603","article-title":"Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity","volume":"128","author":"Czernik","year":"2011","journal-title":"Pediatrics."},{"key":"B116","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/pr.2017.179","article-title":"N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity","volume":"82","author":"B\u00fchrer","year":"2017","journal-title":"Pediatr Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1111\/apa.14354","article-title":"Retinopathy of prematurity screening at \u226530 weeks: urinary NTpro-BNP performance","volume":"107","author":"Berrington","year":"2018","journal-title":"Acta Paediatr."},{"key":"B118","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.9.13.14","article-title":"Cluster analysis of early postnatal biochemical markers may predict development of retinopathy of prematurity","volume":"9","author":"Markasz","year":"2020","journal-title":"Transl Vis Sci Technol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/15513815.2019.1652378","article-title":"Association of eNOS and ACE polymorphisms with retinopathy of prematurity: a systematic review and meta-analysis","volume":"39","author":"Gohari","year":"2020","journal-title":"Fetal Pediatr Pathol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00417-017-3756-0","article-title":"Retinal VEGF levels correlate with ocular circulation measured by a laser speckle-micro system in an oxygen-induced retinopathy rat model","volume":"255","author":"Matsumoto","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00262-016-1792-y","article-title":"Selection and expansion of natural killer cells for NK cell-based immunotherapy","volume":"65","author":"Becker","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s10495-016-1292-8","article-title":"Peripheral blood mononuclear cell secretome for tissue repair","volume":"21","author":"Beer","year":"2016","journal-title":"Apoptosis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/17425255.2018.1500552","article-title":"Quantitation of intracellular triphosphate metabolites of antiretroviral agents in peripheral blood mononuclear cells (PBMCs) and corresponding cell count determinations: review of current methods and challenges","volume":"14","author":"Xiao","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.earlhumdev.2009.06.003","article-title":"Saliva as a valid alternative in monitoring melatonin concentrations in newborn infants","volume":"85","author":"Bagci","year":"2009","journal-title":"Early Hum Dev."},{"key":"B126","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass Spectrom Rev."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/485020a","article-title":"Pre-term births on the rise","volume":"485","author":"Reich","year":"2012","journal-title":"Nature."},{"key":"B129","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/jamaophthalmol.2018.1934","article-title":"Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks","volume":"136","author":"Brown","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"030502","DOI":"10.11613\/BM.2020.030502","article-title":"Inflammatory and angiogenic biomarkers in diabetic retinopathy","volume":"30","author":"Ka\u0161telan","year":"2020","journal-title":"Biochem Med (Zagreb)."},{"key":"B131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2116\/analsci.20SCR04","article-title":"Biomarker analysis on a power-free microfluidic chip driven by degassed poly(dimethylsiloxane)","volume":"37","author":"Hosokawa","year":"2021","journal-title":"Anal Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e1900029","DOI":"10.1002\/pmic.201900029","article-title":"Targeted and untargeted proteomics approaches in biomarker development","volume":"20","author":"Sobsey","year":"2020","journal-title":"Proteomics."},{"key":"B133","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41571-020-00449-x","article-title":"Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy","volume":"18","author":"Gohil","year":"2021","journal-title":"Nat Rev Clin Oncol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.840030\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:51:17Z","timestamp":1643809877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.840030\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":133,"alternative-id":["10.3389\/fmed.2022.840030"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.840030","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"article-number":"840030"}}